Psoriasis Treatment Drugs Market, Global Outlook and Forecast 2022-2028

June 2022 | 103 pages | ID: PEF93A5064E1EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Psoriasis Treatment Drugs in Global, including the following market information:

Global Psoriasis Treatment Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Psoriasis Treatment Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

TNF Inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Psoriasis Treatment Drugs include Amgen, Allergan, Dermira, Eli Lilly, Novartis, Merck, Johnson & Johnson, Pfizer and AstraZeneca, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Psoriasis Treatment Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Psoriasis Treatment Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Psoriasis Treatment Drugs Market Segment Percentages, by Type, 2021 (%)

• TNF Inhibitors
• Interleukin Inhibitors
• Vitamin D Analogs
• Corticosteroids
• Others

Global Psoriasis Treatment Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Psoriasis Treatment Drugs Market Segment Percentages, by Application, 2021 (%)

• Oral
• Parenteral
• Topical

Global Psoriasis Treatment Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Psoriasis Treatment Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Psoriasis Treatment Drugs revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Psoriasis Treatment Drugs revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Amgen
• Allergan
• Dermira
• Eli Lilly
• Novartis
• Merck
• Johnson & Johnson
• Pfizer
• AstraZeneca
• AbbVie
• LEO Pharma
• Biogen
• Galectin Therapeutics
• Cellceutix
• Bayer

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Psoriasis Treatment Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Psoriasis Treatment Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PSORIASIS TREATMENT DRUGS OVERALL MARKET SIZE

2.1 Global Psoriasis Treatment Drugs Market Size: 2021 VS 2028
2.2 Global Psoriasis Treatment Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Psoriasis Treatment Drugs Players in Global Market
3.2 Top Global Psoriasis Treatment Drugs Companies Ranked by Revenue
3.3 Global Psoriasis Treatment Drugs Revenue by Companies
3.4 Top 3 and Top 5 Psoriasis Treatment Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Psoriasis Treatment Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Psoriasis Treatment Drugs Players in Global Market
  3.6.1 List of Global Tier 1 Psoriasis Treatment Drugs Companies
  3.6.2 List of Global Tier 2 and Tier 3 Psoriasis Treatment Drugs Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Psoriasis Treatment Drugs Market Size Markets, 2021 & 2028
  4.1.2 TNF Inhibitors
  4.1.3 Interleukin Inhibitors
  4.1.4 Vitamin D Analogs
  4.1.5 Corticosteroids
  4.1.6 Others
4.2 By Type - Global Psoriasis Treatment Drugs Revenue & Forecasts
  4.2.1 By Type - Global Psoriasis Treatment Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Psoriasis Treatment Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Psoriasis Treatment Drugs Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Psoriasis Treatment Drugs Market Size, 2021 & 2028
  5.1.2 Oral
  5.1.3 Parenteral
  5.1.4 Topical
5.2 By Application - Global Psoriasis Treatment Drugs Revenue & Forecasts
  5.2.1 By Application - Global Psoriasis Treatment Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Psoriasis Treatment Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Psoriasis Treatment Drugs Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Psoriasis Treatment Drugs Market Size, 2021 & 2028
6.2 By Region - Global Psoriasis Treatment Drugs Revenue & Forecasts
  6.2.1 By Region - Global Psoriasis Treatment Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Psoriasis Treatment Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Psoriasis Treatment Drugs Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Psoriasis Treatment Drugs Revenue, 2017-2028
  6.3.2 US Psoriasis Treatment Drugs Market Size, 2017-2028
  6.3.3 Canada Psoriasis Treatment Drugs Market Size, 2017-2028
  6.3.4 Mexico Psoriasis Treatment Drugs Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Psoriasis Treatment Drugs Revenue, 2017-2028
  6.4.2 Germany Psoriasis Treatment Drugs Market Size, 2017-2028
  6.4.3 France Psoriasis Treatment Drugs Market Size, 2017-2028
  6.4.4 U.K. Psoriasis Treatment Drugs Market Size, 2017-2028
  6.4.5 Italy Psoriasis Treatment Drugs Market Size, 2017-2028
  6.4.6 Russia Psoriasis Treatment Drugs Market Size, 2017-2028
  6.4.7 Nordic Countries Psoriasis Treatment Drugs Market Size, 2017-2028
  6.4.8 Benelux Psoriasis Treatment Drugs Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Psoriasis Treatment Drugs Revenue, 2017-2028
  6.5.2 China Psoriasis Treatment Drugs Market Size, 2017-2028
  6.5.3 Japan Psoriasis Treatment Drugs Market Size, 2017-2028
  6.5.4 South Korea Psoriasis Treatment Drugs Market Size, 2017-2028
  6.5.5 Southeast Asia Psoriasis Treatment Drugs Market Size, 2017-2028
  6.5.6 India Psoriasis Treatment Drugs Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Psoriasis Treatment Drugs Revenue, 2017-2028
  6.6.2 Brazil Psoriasis Treatment Drugs Market Size, 2017-2028
  6.6.3 Argentina Psoriasis Treatment Drugs Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Psoriasis Treatment Drugs Revenue, 2017-2028
  6.7.2 Turkey Psoriasis Treatment Drugs Market Size, 2017-2028
  6.7.3 Israel Psoriasis Treatment Drugs Market Size, 2017-2028
  6.7.4 Saudi Arabia Psoriasis Treatment Drugs Market Size, 2017-2028
  6.7.5 UAE Psoriasis Treatment Drugs Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Amgen
  7.1.1 Amgen Corporate Summary
  7.1.2 Amgen Business Overview
  7.1.3 Amgen Psoriasis Treatment Drugs Major Product Offerings
  7.1.4 Amgen Psoriasis Treatment Drugs Revenue in Global Market (2017-2022)
  7.1.5 Amgen Key News
7.2 Allergan
  7.2.1 Allergan Corporate Summary
  7.2.2 Allergan Business Overview
  7.2.3 Allergan Psoriasis Treatment Drugs Major Product Offerings
  7.2.4 Allergan Psoriasis Treatment Drugs Revenue in Global Market (2017-2022)
  7.2.5 Allergan Key News
7.3 Dermira
  7.3.1 Dermira Corporate Summary
  7.3.2 Dermira Business Overview
  7.3.3 Dermira Psoriasis Treatment Drugs Major Product Offerings
  7.3.4 Dermira Psoriasis Treatment Drugs Revenue in Global Market (2017-2022)
  7.3.5 Dermira Key News
7.4 Eli Lilly
  7.4.1 Eli Lilly Corporate Summary
  7.4.2 Eli Lilly Business Overview
  7.4.3 Eli Lilly Psoriasis Treatment Drugs Major Product Offerings
  7.4.4 Eli Lilly Psoriasis Treatment Drugs Revenue in Global Market (2017-2022)
  7.4.5 Eli Lilly Key News
7.5 Novartis
  7.5.1 Novartis Corporate Summary
  7.5.2 Novartis Business Overview
  7.5.3 Novartis Psoriasis Treatment Drugs Major Product Offerings
  7.5.4 Novartis Psoriasis Treatment Drugs Revenue in Global Market (2017-2022)
  7.5.5 Novartis Key News
7.6 Merck
  7.6.1 Merck Corporate Summary
  7.6.2 Merck Business Overview
  7.6.3 Merck Psoriasis Treatment Drugs Major Product Offerings
  7.6.4 Merck Psoriasis Treatment Drugs Revenue in Global Market (2017-2022)
  7.6.5 Merck Key News
7.7 Johnson & Johnson
  7.7.1 Johnson & Johnson Corporate Summary
  7.7.2 Johnson & Johnson Business Overview
  7.7.3 Johnson & Johnson Psoriasis Treatment Drugs Major Product Offerings
  7.7.4 Johnson & Johnson Psoriasis Treatment Drugs Revenue in Global Market (2017-2022)
  7.7.5 Johnson & Johnson Key News
7.8 Pfizer
  7.8.1 Pfizer Corporate Summary
  7.8.2 Pfizer Business Overview
  7.8.3 Pfizer Psoriasis Treatment Drugs Major Product Offerings
  7.8.4 Pfizer Psoriasis Treatment Drugs Revenue in Global Market (2017-2022)
  7.8.5 Pfizer Key News
7.9 AstraZeneca
  7.9.1 AstraZeneca Corporate Summary
  7.9.2 AstraZeneca Business Overview
  7.9.3 AstraZeneca Psoriasis Treatment Drugs Major Product Offerings
  7.9.4 AstraZeneca Psoriasis Treatment Drugs Revenue in Global Market (2017-2022)
  7.9.5 AstraZeneca Key News
7.10 AbbVie
  7.10.1 AbbVie Corporate Summary
  7.10.2 AbbVie Business Overview
  7.10.3 AbbVie Psoriasis Treatment Drugs Major Product Offerings
  7.10.4 AbbVie Psoriasis Treatment Drugs Revenue in Global Market (2017-2022)
  7.10.5 AbbVie Key News
7.11 LEO Pharma
  7.11.1 LEO Pharma Corporate Summary
  7.11.2 LEO Pharma Business Overview
  7.11.3 LEO Pharma Psoriasis Treatment Drugs Major Product Offerings
  7.11.4 LEO Pharma Psoriasis Treatment Drugs Revenue in Global Market (2017-2022)
  7.11.5 LEO Pharma Key News
7.12 Biogen
  7.12.1 Biogen Corporate Summary
  7.12.2 Biogen Business Overview
  7.12.3 Biogen Psoriasis Treatment Drugs Major Product Offerings
  7.12.4 Biogen Psoriasis Treatment Drugs Revenue in Global Market (2017-2022)
  7.12.5 Biogen Key News
7.13 Galectin Therapeutics
  7.13.1 Galectin Therapeutics Corporate Summary
  7.13.2 Galectin Therapeutics Business Overview
  7.13.3 Galectin Therapeutics Psoriasis Treatment Drugs Major Product Offerings
  7.13.4 Galectin Therapeutics Psoriasis Treatment Drugs Revenue in Global Market (2017-2022)
  7.13.5 Galectin Therapeutics Key News
7.14 Cellceutix
  7.14.1 Cellceutix Corporate Summary
  7.14.2 Cellceutix Business Overview
  7.14.3 Cellceutix Psoriasis Treatment Drugs Major Product Offerings
  7.14.4 Cellceutix Psoriasis Treatment Drugs Revenue in Global Market (2017-2022)
  7.14.5 Cellceutix Key News
7.15 Bayer
  7.15.1 Bayer Corporate Summary
  7.15.2 Bayer Business Overview
  7.15.3 Bayer Psoriasis Treatment Drugs Major Product Offerings
  7.15.4 Bayer Psoriasis Treatment Drugs Revenue in Global Market (2017-2022)
  7.15.5 Bayer Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Psoriasis Treatment Drugs Market Opportunities & Trends in Global Market
Table 2. Psoriasis Treatment Drugs Market Drivers in Global Market
Table 3. Psoriasis Treatment Drugs Market Restraints in Global Market
Table 4. Key Players of Psoriasis Treatment Drugs in Global Market
Table 5. Top Psoriasis Treatment Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Psoriasis Treatment Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Psoriasis Treatment Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Psoriasis Treatment Drugs Product Type
Table 9. List of Global Tier 1 Psoriasis Treatment Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Psoriasis Treatment Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Psoriasis Treatment Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Psoriasis Treatment Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Psoriasis Treatment Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Psoriasis Treatment Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Psoriasis Treatment Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Psoriasis Treatment Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Psoriasis Treatment Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Psoriasis Treatment Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Psoriasis Treatment Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Psoriasis Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Psoriasis Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Psoriasis Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Psoriasis Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Psoriasis Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Psoriasis Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Psoriasis Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Psoriasis Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Psoriasis Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Psoriasis Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Amgen Corporate Summary
Table 31. Amgen Psoriasis Treatment Drugs Product Offerings
Table 32. Amgen Psoriasis Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Allergan Corporate Summary
Table 34. Allergan Psoriasis Treatment Drugs Product Offerings
Table 35. Allergan Psoriasis Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Dermira Corporate Summary
Table 37. Dermira Psoriasis Treatment Drugs Product Offerings
Table 38. Dermira Psoriasis Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Eli Lilly Corporate Summary
Table 40. Eli Lilly Psoriasis Treatment Drugs Product Offerings
Table 41. Eli Lilly Psoriasis Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Novartis Corporate Summary
Table 43. Novartis Psoriasis Treatment Drugs Product Offerings
Table 44. Novartis Psoriasis Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Merck Corporate Summary
Table 46. Merck Psoriasis Treatment Drugs Product Offerings
Table 47. Merck Psoriasis Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Johnson & Johnson Corporate Summary
Table 49. Johnson & Johnson Psoriasis Treatment Drugs Product Offerings
Table 50. Johnson & Johnson Psoriasis Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Pfizer Corporate Summary
Table 52. Pfizer Psoriasis Treatment Drugs Product Offerings
Table 53. Pfizer Psoriasis Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 54. AstraZeneca Corporate Summary
Table 55. AstraZeneca Psoriasis Treatment Drugs Product Offerings
Table 56. AstraZeneca Psoriasis Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 57. AbbVie Corporate Summary
Table 58. AbbVie Psoriasis Treatment Drugs Product Offerings
Table 59. AbbVie Psoriasis Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 60. LEO Pharma Corporate Summary
Table 61. LEO Pharma Psoriasis Treatment Drugs Product Offerings
Table 62. LEO Pharma Psoriasis Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 63. Biogen Corporate Summary
Table 64. Biogen Psoriasis Treatment Drugs Product Offerings
Table 65. Biogen Psoriasis Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 66. Galectin Therapeutics Corporate Summary
Table 67. Galectin Therapeutics Psoriasis Treatment Drugs Product Offerings
Table 68. Galectin Therapeutics Psoriasis Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 69. Cellceutix Corporate Summary
Table 70. Cellceutix Psoriasis Treatment Drugs Product Offerings
Table 71. Cellceutix Psoriasis Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 72. Bayer Corporate Summary
Table 73. Bayer Psoriasis Treatment Drugs Product Offerings
Table 74. Bayer Psoriasis Treatment Drugs Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Psoriasis Treatment Drugs Segment by Type in 2021
Figure 2. Psoriasis Treatment Drugs Segment by Application in 2021
Figure 3. Global Psoriasis Treatment Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Psoriasis Treatment Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Psoriasis Treatment Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Psoriasis Treatment Drugs Revenue in 2021
Figure 8. By Type - Global Psoriasis Treatment Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Psoriasis Treatment Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Psoriasis Treatment Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Psoriasis Treatment Drugs Revenue Market Share, 2017-2028
Figure 12. US Psoriasis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Psoriasis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Psoriasis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Psoriasis Treatment Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Psoriasis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Psoriasis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Psoriasis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Psoriasis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Psoriasis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Psoriasis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Psoriasis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Psoriasis Treatment Drugs Revenue Market Share, 2017-2028
Figure 24. China Psoriasis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Psoriasis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Psoriasis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Psoriasis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Psoriasis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Psoriasis Treatment Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Psoriasis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Psoriasis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Psoriasis Treatment Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Psoriasis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Psoriasis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Psoriasis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Psoriasis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Amgen Psoriasis Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Allergan Psoriasis Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Dermira Psoriasis Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Eli Lilly Psoriasis Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Novartis Psoriasis Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Merck Psoriasis Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Johnson & Johnson Psoriasis Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Pfizer Psoriasis Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. AstraZeneca Psoriasis Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. AbbVie Psoriasis Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. LEO Pharma Psoriasis Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Biogen Psoriasis Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Galectin Therapeutics Psoriasis Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Cellceutix Psoriasis Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Bayer Psoriasis Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)